BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8615011)

  • 21. Cleavage of synthetic peptides by purified poliovirus 3C proteinase.
    Pallai PV; Burkhardt F; Skoog M; Schreiner K; Bax P; Cohen KA; Hansen G; Palladino DE; Harris KS; Nicklin MJ
    J Biol Chem; 1989 Jun; 264(17):9738-41. PubMed ID: 2542331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subdomain specific functions of the RNA polymerase region of poliovirus 3CD polypeptide.
    Cornell CT; Semler BL
    Virology; 2002 Jul; 298(2):200-13. PubMed ID: 12127783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing of a cellular polypeptide by 3CD proteinase is required for poliovirus ribonucleoprotein complex formation.
    Roehl HH; Parsley TB; Ho TV; Semler BL
    J Virol; 1997 Jan; 71(1):578-85. PubMed ID: 8985386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of poliovirus 3C protease by the 2C polypeptide.
    Banerjee R; Weidman MK; Echeverri A; Kundu P; Dasgupta A
    J Virol; 2004 Sep; 78(17):9243-56. PubMed ID: 15308719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of active-site amino acid residues in the Chiba virus 3C-like protease.
    Someya Y; Takeda N; Miyamura T
    J Virol; 2002 Jun; 76(12):5949-58. PubMed ID: 12021327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C.
    Zell R; Sidigi K; Bucci E; Stelzner A; Görlach M
    RNA; 2002 Feb; 8(2):188-201. PubMed ID: 11911365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
    Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of P2 cleavage site mutations on poliovirus polyprotein processing.
    Cohen L; Kean KM; Girard M; Van der Werf S
    Virology; 1996 Oct; 224(1):34-42. PubMed ID: 8862397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification, properties, and mutagenesis of poliovirus 3C protease.
    Baum EZ; Bebernitz GA; Palant O; Mueller T; Plotch SJ
    Virology; 1991 Nov; 185(1):140-50. PubMed ID: 1656583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus.
    Grubman MJ; Zellner M; Bablanian G; Mason PW; Piccone ME
    Virology; 1995 Nov; 213(2):581-9. PubMed ID: 7491782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-directed mutagenesis of the putative active site residues of 3C proteinase of coxsackievirus B3: evidence of a functional relationship with trypsin-like serine proteinases.
    Miyashita K; Kusumi M; Utsumi R; Katayama S; Noda M; Komano T; Satoh N
    Protein Eng; 1993 Feb; 6(2):189-93. PubMed ID: 8386363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.
    Ventoso I; Carrasco L
    J Virol; 1995 Oct; 69(10):6280-8. PubMed ID: 7666528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase.
    Davis GJ; Wang QM; Cox GA; Johnson RB; Wakulchik M; Dotson CA; Villarreal EC
    Arch Biochem Biophys; 1997 Oct; 346(1):125-30. PubMed ID: 9328292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel point mutation (L70P) inactivates poliovirus 3C protease.
    Uma M; Hegde SR; Rao PP; Nagalekshmi K; Gauthami S; Kumar D; Hegde NR
    Acta Virol; 2018; 62(1):68-77. PubMed ID: 29521105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.
    Molla A; Hellen CU; Wimmer E
    J Virol; 1993 Aug; 67(8):4688-95. PubMed ID: 8392608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poliovirus/Hepatitis C virus (internal ribosomal entry site-core) chimeric viruses: improved growth properties through modification of a proteolytic cleavage site and requirement for core RNA sequences but not for core-related polypeptides.
    Zhao WD; Wimmer E; Lahser FC
    J Virol; 1999 Feb; 73(2):1546-54. PubMed ID: 9882360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase.
    Ypma-Wong MF; Semler BL
    Nucleic Acids Res; 1987 Mar; 15(5):2069-88. PubMed ID: 3031587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.